Resumen

MONTIEL RAMOS, Jehidys Estella et al. Comparison of the ATB^® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp. Rev. Univ. Ind. Santander. Salud [online]. 2014, vol.46, n.1, pp.7-14. ISSN 0121-0807.

The increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Testing of the Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) for the evaluation of the susceptibility of isolates of Candida spp. to three agents. The percentage of agreement was calculated based on the minimum inhibitory concentrations. There was a high correlation for AMB (100% қ = 1.0 Bhapkar coefficient p = 1.0); while it was lower with azoles (85%, қ = 0.41, p = Bhapkar coefficient 0.02 and 83.0%, қ = 0.15, Bhapkar coefficient p = 0.0006, respectively). The ATB® Fungus 2 and AFST-EUCAST are fully comparable methods for testing the susceptibility to AMB and to lesser extend comparable for ITR and FCA

Palabras clave : antifungal susceptibility; Candida spp; ATB® Fungus 2; AFST-EUCAST; susceptibilidad antifúngica; Candida spp; ATB® Fungus 2; AFST-EUCAST.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )